Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2018Journal of Clinical OncologyOpen Access

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

DKDavid M. KurtzUniversity of Nebraska at OmahaFSFlorian SchererUniversity of FreiburgMJMichael C. JinHarbin Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kurtz et al. (2018) studied this question.

synapsesocial.com/papers/6a08fc7ea2bc65e38873b17ahttps://doi.org/10.1200/jco.2018.78.5246
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diffuse large B-cell lymphoma genotyping on the liquid biopsy2017 · 264 citations
  2. 2Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing2015 · 344 citations
  3. 3Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-142016 · 57 citations
  4. 4Interim [ 18 F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab2011 · 162 citations
  5. 5Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma2016 · 74 citations